Browse > Article

Studies on the Processing of Herbal Medicines (III) -HPLC Analysis of Magnolol and Inhibitory Effects on the Formation of Advanced Glycation Endproducts(AGEs) in Vitro of Unprocessed-and Processed Magnolia Bark-  

Kim, Hyeun-Jeong (Department of Herbal Pharmaceutical Development, Korea Institute of Oriental Medicine)
Ko, Jin-Hee (Department of Herbal Pharmaceutical Development, Korea Institute of Oriental Medicine)
Kim, Jin-Sook (Department of Herbal Pharmaceutical Development, Korea Institute of Oriental Medicine)
Publication Information
Korean Journal of Pharmacognosy / v.33, no.4, 2002 , pp. 308-311 More about this Journal
Abstract
Advanced glycation end products(AGEs) are largly involved in the pathogenesis of diabetic nephropathy. It is obvious that inhibition of AGEs formation is important in preventing the occurrence and progression of diabetic nephropathy. In diabetes, this reaction is greatly accerated and is important in the pathogenesis of diabetic complications, especially diabetic nephropathy. Therefore, to seek possible AGEs inhibitors in herbal medicines, unprocessed - and processed Magnolia Bark were examined in vitro as basic data for aniaml experiment. The content of magnolol in unprocessed Magnolia Bark was $0.796{\pm}0.072%$, and after processing was decreased to $0.586{\pm}0.101%(p<0.01)$. The content of AGEs was measured by their intrinsic fluorescence. The $IC_{50}({\mu}g/ml)$ values of aminoguanidine, unprocessed- and procesled Magnolia Bark are $38.845{\pm}8.36{\mu}g/ml$, $54.264{\pm}3.153{\mu}g/ml$ and $27.882{\pm}1.836{\mu}g/ml$, respectively. This result means that prcessed Magnolia Bark was more effective than aminoguanidine, as positive control.
Keywords
processing; Magnolia Bark; magnolol; advanced glycation endproduct(AGEs); diabetic nephropathy;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Park, Y, Lee, H., Koh, C.S., Min, H., Yoo, K., Kirn, Y. and Shin, Y. (1995) Prevalence of diabetes and IGT in Yonchon County, South, Korea. Diabetes care 18: 545-548   DOI   ScienceOn
2 Yokozawa, T., Nakagawa, T. and Terasawa, K. (2001) Effects of oriental medicines on the production of advanced glycation products. J. of Trad. Med. 18: 107-112
3 Park, H.J., Kwon, S.H., Han, Y.N., Choi, J.W., Miyarnoto, K., Lee, S.H. and Lee, K.T. (2001) Apoptosis-inducing costunolide and a novel acyclic monoterpene from the stem bark of Magnolia sieboldii. Arch. Pharm. Res. 24: 342-348   DOI   ScienceOn
4 Bang, K.H., Kim, Y.K., Min, B.S., Na M.K., Rhee, Y.H., Lee, J.P. and Bae, K.H. (2000) Antifungal activity of magnolol and honokiol. Arch. Pharm. Res. 23: 46-49   DOI   ScienceOn
5 생약.한약재 품질 표준화연구보고서(1996) 199. 식품의약품안전청, 서울
6 김호철, 김진숙(2001) 한약재 수치법제의 규격화연구, 보건의료기술연구개 발사업최종보고서(00-PJ6-PG5-00-0001), 서울
7 Vlassara, H., Striker, L. J., Teichberg, S., Fuh, H., Li. Y.M. and Steffs, M. (1994) Advanced glycation end products induce glomerular sclerosis and albuminuna in normal rats. Proc. Natl. Acad. Sci. 89: 2873-2877
8 국가약전위원회(2000) 중화민국공화국약전, I부, 204. 화학공업출판사, 북경
9 Konoshima, T., Kozuka, M., Tokuda, H., Nishino, H., Iwashima, A., Haruna, M., Ito, K. and Tanabe, M. (1991)Studies on inhibitors of skin tumor promotion, IX. Neolignans from Magnolia officinalis. J. Nat. Prod., 54: 816-822   DOI   PUBMED
10 Smith, P.R. and Thomalley, P.J. (1992) Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. Eur. J. Biochem. 210: 729-739   DOI   ScienceOn
11 Nakagawa, T, Yokozawa, T. and Terasawa, K. (2001) A study of Kampo medicines in a diabetic nephrophathymodel. J. of Trad. Med. 18: 161-168
12 Son, H.J., Lee, H.J., Yun-Choi, H.S. and Ryu, J.H. (2000) Inhibitors of nitric oxide synthesis and TNF-alpha expression from Magnolia obovata in activated macrophages. Ptanta Med. 66: 467-471
13 Edelstein, D. and Brownlee, M. (1992) Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41: 26-29   DOI   ScienceOn
14 Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P. and Cerami, A. (1986) Aminoguamdine prevents diabetes-induced arterial wall protein cross-linking, Sciences 232: 1629-1632   DOI
15 Kuribara, H., Stavinoha, W..B. and Maruyama, Y. (1999) Honokiol, a putative anxiolytic agent extracted from magnolia bark, has no diazepam like side effects in mice. J. Pharm. Pharmacol. 51: 97-103
16 Shin, T.Y, Kim, D.K., Chae, B.S. and Lee, EJ. (2001) Antiallergic action of Magnolia officinalis on immediate hypersensitivity reaction. Arch. Pharm. Res. 24: 249-255   DOI   ScienceOn
17 Vinson, J.A. and Howard, T.B. III (1996) Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. Nutritional Biochemistry 7: 659-663   DOI   ScienceOn
18 Ikarashi, Y, Yuzurihara, M., Sakakibara, I., Nakai, Y, Hattori, N. and Maruyama, Y. (2001) Effects of extract of the bark of Magnolia obovata and its biphenolic constituents magnolol and honokiol on histamine release from peritoneal mast cells in rats. Planta Med. 67: 709-713   DOI   ScienceOn